「清晰」是什麼意思?
該動物不攜帶突變。就不會發展成這種疾病 並且不會傳遞下去。
Alpha-Mannosidosis (AMD) in dogs is a rare genetic disorder caused by a deficiency of the enzyme alpha-mannosidase. Early DNA testing for AMD helps breeders identify carriers and prevent the spread of this inherited condition. Accurate DNA tests enable responsible breeding decisions, reducing the risk of affected puppies. Symptoms of AMD include developmental delays, muscle weakness, and neurological issues. By utilizing advanced genetic screening, dog owners can ensure healthier litters and improve overall breed health. Regular DNA testing for Alpha-Mannosidosis is essential for maintaining the well-being of susceptible dog breeds. Protect your dog’s future with reliable AMD DNA testing today.
Alpha-Mannosidosis (AMD) is a rare genetic disorder in dogs caused by a deficiency of the enzyme alpha-mannosidase. This enzyme deficiency leads to the accumulation of complex sugars in cells, causing progressive neurological and physical symptoms. DNA testing for AMD helps identify carriers and affected dogs, enabling responsible breeding decisions. Early diagnosis through genetic screening can improve management and care for affected dogs. This test is essential for breeders aiming to reduce the incidence of AMD in their lines.
我們的包裝中已包含此 DNA 測試 Basic — 也是包包的一部分 Basic, Standard, Advanced, Complete。
查看 DNA 測試包 →Alpha-Mannosidosis (AMD) is a rare genetic disorder that affects the metabolism of certain sugars in the body. It is caused by a deficiency of the enzyme alpha-mannosidase, which is crucial for breaking down complex carbohydrates. When this enzyme is lacking or dysfunctional, toxic substances can accumulate in the cells, leading to a range of health issues. This condition can impact various organ systems and is characterized by a variety of symptoms that can significantly affect a dog's quality of life.
Dogs with Alpha-Mannosidosis may exhibit a range of clinical signs, which can vary in severity. Common symptoms include developmental delays, neurological problems, and skeletal abnormalities. Affected dogs may experience difficulty with movement, including weakness in the limbs and impaired coordination. Additionally, they may show signs of cognitive deficits, such as disorientation or changes in behavior. Other symptoms can include enlarged organs, particularly the liver and spleen, and recurrent infections due to a compromised immune system.
The diagnosis of Alpha-Mannosidosis typically involves a combination of clinical evaluation and laboratory testing. Veterinarians may suspect AMD based on the presence of characteristic symptoms and the dog's medical history. Confirmatory diagnosis is achieved through specialized testing, including biochemical assays to measure enzyme activity and genetic testing to identify mutations in the gene responsible for the condition. DNA testing is a crucial tool in confirming the presence of the disorder and understanding its genetic basis.
Currently, there is no cure for Alpha-Mannosidosis, and treatment focuses primarily on managing symptoms and improving the quality of life for affected dogs. Supportive care may include physical therapy to help maintain mobility, nutritional support to address any dietary needs, and medication to manage secondary infections or complications. In some cases, enzyme replacement therapy is being explored as a potential treatment option, although it is not widely available for veterinary use yet. Regular veterinary check-ups are essential to monitor the dog's health and adjust the management plan as needed.
Genetic testing for Alpha-Mannosidosis plays a vital role in breeding programs and can help prevent the spread of this condition within canine populations. By identifying carriers of the gene mutation, breeders can make informed decisions to reduce the incidence of AMD in future generations. This proactive approach not only protects the health of individual dogs but also contributes to the overall welfare of the breed.
Alpha-Mannosidosis is a serious genetic condition that poses significant challenges for affected dogs and their owners. Understanding the nature of the disorder, its symptoms, and the importance of early diagnosis and management can help improve outcomes for these pets. Genetic testing is an essential tool in both diagnosis and prevention, allowing for responsible breeding practices that can minimize the impact of this disease in the canine population.
該動物不攜帶突變。就不會發展成這種疾病 並且不會傳遞下去。
不會。該動物通常是健康的,但可以將突變傳播給它的 後代。
它攜帶兩個突變的副本。預計臨床症狀取決於 這種疾病。它不應該被培育。
有些疾病與性別有關,因此其表現因性別而異 動物的性別。
This DNA test detects the mutation associated with Alpha-Mannosidosis (AMD) in order to identify clear, carrier, or at-risk animals.
DNA 測試有助於飼養員計劃更安全的交配並降低將突變傳播給後代的風險。
此測試報告的遺傳模式是體染色體隱性遺傳。
This test analyses the mutation MAN2B1 c.311A>G.
未必。解釋取決於遺傳模式和產生的基因型。
Bullock Garrett, Johnson Gary S, Pattridge Savannah G, MhlangaMutangadura Tendai, Guo Juyuan, Cook James, Campbell Rebecca S, Vite Charles H, Katz Martin L. A Homozygous MAN2B1 Missense Mutation in a Doberman Pinscher Dog with Neurodegeneration, Cytoplasmic Vacuoles, Autofluorescent Storage Granules, and an ?-Mannosidase Deficiency. Genes (Basel). 2023 Aug 31;14(9):1746. doi: 10.3390/genes14091746.